{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:34:16Z","timestamp":1759484056379},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.clinthera.2007.02.002","type":"journal-article","created":{"date-parts":[[2007,4,30]],"date-time":"2007-04-30T14:49:32Z","timestamp":1177944572000},"page":"352-356","source":"Crossref","is-referenced-by-count":5,"title":["Cinacalcet-associated cardiogenic shock in a patient with cardiomyopathy"],"prefix":"10.1016","volume":"29","author":[{"given":"Lindsey","family":"Tilling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Colin Forfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2007.02.002_bib1","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1345\/aph.1D108","article-title":"Calcimimetics and the treatment of primary and secondary hyperparathy roidism","volume":"38","author":"Joy","year":"2004","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.clinthera.2007.02.002_bib2","series-title":"Sensipar [package insert]","year":"2004"},{"key":"10.1016\/j.clinthera.2007.02.002_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.clinthera.2007.02.002_bib4","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.clinthera.2005.11.015","article-title":"Cinacalcet: An oral calcinnimetic agent for the management of hyperparathyroidism","volume":"27","author":"Dong","year":"2005","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2007.02.002_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for esti-mating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2007.02.002_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/01.RES.0000243978.15182.c1","article-title":"Reduced cardiac L-type Ca2+ current in Ca(V)heca2-\/- embryos impairs cardiac development and contraction with secondary defects in vascularmaturation","volume":"99","author":"Weissgerber","year":"2006","journal-title":"Circ Res."},{"key":"10.1016\/j.clinthera.2007.02.002_bib7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bmj.308.6935.992","article-title":"Treating overdose with calcium channel blockers","volume":"308","author":"Kenny","year":"1994","journal-title":"BMJ."},{"key":"10.1016\/j.clinthera.2007.02.002_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0196-0644(05)82469-2","article-title":"Calcium channel blocker toxicity","volume":"19","author":"Ramoska","year":"1990","journal-title":"Ann Emerg Med."},{"key":"10.1016\/j.clinthera.2007.02.002_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intra-venous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomiseddouble-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2007.02.002_bib10","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","article-title":"Safety and efficacy of a novel calcium sensitizer, levosi-mendan, in patients with left ventricular failure due to an acute myocardial infarction; a randomized, placebo-controlled, doubleblind study (RUSSLAN)","volume":"23","author":"Moiseyev","year":"2002","journal-title":"Eur Heart J"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T22:57:40Z","timestamp":1546901860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291807000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0149291807000434"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2007.02.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}